Second- and third-line treatment agents in autoimmune hepatitis (AIH): Where do we stand? by Pinelopi Arvaniti, Ignasi Olivas, Sergio Rodriguez-Tajes, George N. Dalekos, Maria-Carlota Londoño

Get full text

Detection of M2-Type Anti-Mitochondrial Autoantibodies against Specific Subunits in the Diagnosis of Primary Biliary Cholangitis in Patients with Discordant Results by Cristina Arnaldos-Pérez, Albert Pérez-Isidro, Uma Bolos, Carmen Domènech, Judit Ballús, Sergio Rodríguez-Tajes, María Carlota Londoño, Odette Viñas, Estíbaliz Ruiz-Ortiz

Get full text

Quo vadis autoimmune hepatitis? - Summary of the 5th international autoimmune hepatitis group research workshop 2024Keypoints by Bastian Engel, David N. Assis, Mamatha Bhat, Jan Clusmann, Joost PH. Drenth, Alessio Gerussi, María-Carlota Londoño, Ye Htun Oo, Ida Schregel, Marcial Sebode, Richard Taubert

Get full text

Liver stiffness measurement predicts clinical outcomes in autoimmune hepatitis by Ignasi Olivas, Pinelopi Arvaniti, Stella Gabeta, Sonia Torres, Maria Del Barrio, Alvaro Díaz-González, Paula Esteban, Mar Riveiro-Barciela, Ezequiel Mauro, Sergio Rodríguez-Tajes, Kalliopi Zachou, George N. Dalekos, María-Carlota Londoño

Get full text

Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon. by Martina Gambato, Noelia Caro-Pérez, Patricia González, Nuria Cañete, Zoe Mariño, Sabela Lens, Martín Bonacci, Concepció Bartres, José-María Sánchez-Tapias, José A Carrión, Xavier Forns, Manel Juan, Sofía Pérez-Del-Pulgar, María-Carlota Londoño

Get full text

Correction: Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interfe... by Martina Gambato, Noelia Caro-Pérez, Patricia González, Nuria Cañete, Zoe Mariño, Sabela Lens, Martín Bonacci, Concepció Bartres, José-María Sánchez-Tapias, José A Carrión, Xavier Forns, Manel Juan, Sofía Pérez-Del-Pulgar, María-Carlota Londoño

Get full text

Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study by Ana Barreira-Díaz, Mar Riveiro-Barciela, Eva María Fernández-Bonilla, Vanesa Bernal, Agustín Castiella, Marta Casado-Martín, Carolina Delgado, María-Carlota Londoño, Álvaro Díaz-González, Indhira Pérez-Medrano, Andrés Conthe, Margarita Sala, Beatriz Mateos, Judith Gómez-Camarero, Dolores Antón-Conejero, Carmen Del Pozo-Calzada, Francisca Cuenca, Ares Villagrasa-Vilella, Magdalena Salcedo

Get full text

Noninvasive Prediction of Outcomes in Autoimmune Hepatitis–Related Cirrhosis by Laura‐Patricia Llovet, Jordi Gratacós‐Ginès, Luis Téllez, Ana Gómez‐Outomuro, Carmen A. Navascués, Mar Riveiro‐Barciela, Raquel Vinuesa, Judith Gómez‐Camarero, Montserrat García‐Retortillo, Fernando Díaz‐Fontenla, Magdalena Salcedo, María García‐Eliz, Diana Horta, Marta Guerrero, Manuel Rodríguez‐Perálvarez, Conrado Fernández‐Rodriguez, Agustín Albillos, Juan G‐Abraldes, Albert Parés, Maria‐Carlota Londoño

Get full text

Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease by Lorenz Kocheise, Lorenz Kocheise, Ignazio Piseddu, Ignazio Piseddu, Joscha Vonderlin, Joscha Vonderlin, Eric T. Tjwa, Eric T. Tjwa, Gustav Buescher, Gustav Buescher, Lucy Meunier, Lucy Meunier, Pia Goeggelmann, Francesca Fianchi, Francesca Fianchi, Jérôme Dumortier, Jérôme Dumortier, Mar Riveiro Barciela, Mar Riveiro Barciela, Tom J. G. Gevers, Tom J. G. Gevers, Tom J. G. Gevers, Benedetta Terziroli Beretta-Piccoli, Benedetta Terziroli Beretta-Piccoli, Benedetta Terziroli Beretta-Piccoli, Benedetta Terziroli Beretta-Piccoli, Maria-Carlota Londoño, Maria-Carlota Londoño, Sona Frankova, Sona Frankova, Thomas Roesner, Vincent Joerg, Vincent Joerg, Constantin Schmidt, Constantin Schmidt, Fabian Glaser, Fabian Glaser, Jan P. Sutter, Jan P. Sutter, Thorben W. Fründt, Thorben W. Fründt, Ansgar W. Lohse, Ansgar W. Lohse, Samuel Huber, Samuel Huber, Johann von Felden, Johann von Felden, Marcial Sebode, Marcial Sebode, Kornelius Schulze, Kornelius Schulze

Get full text

PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease by Lorenz Kocheise, Lorenz Kocheise, Ignazio Piseddu, Ignazio Piseddu, Joscha Vonderlin, Joscha Vonderlin, Eric T. Tjwa, Eric T. Tjwa, Gustav Buescher, Gustav Buescher, Lucy Meunier, Lucy Meunier, Pia Goeggelmann, Francesca Fianchi, Francesca Fianchi, Jérôme Dumortier, Jérôme Dumortier, Mar Riveiro Barciela, Mar Riveiro Barciela, Tom J. G. Gevers, Tom J. G. Gevers, Tom J. G. Gevers, Benedetta Terziroli Beretta-Piccoli, Benedetta Terziroli Beretta-Piccoli, Benedetta Terziroli Beretta-Piccoli, Benedetta Terziroli Beretta-Piccoli, Maria-Carlota Londoño, Maria-Carlota Londoño, Sona Frankova, Sona Frankova, Thomas Roesner, Vincent Joerg, Vincent Joerg, Constantin Schmidt, Constantin Schmidt, Fabian Glaser, Fabian Glaser, Jan P. Sutter, Jan P. Sutter, Thorben W. Fründt, Thorben W. Fründt, Ansgar W. Lohse, Ansgar W. Lohse, Samuel Huber, Samuel Huber, Johann von Felden, Johann von Felden, Marcial Sebode, Marcial Sebode, Kornelius Schulze, Kornelius Schulze

Get full text

OP-1 LONG-TERM EFFICACY AND SAFETY OF OPEN-LABEL SELADELPAR TREATMENT IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS: INTERIM 2-YEAR RESULTS FROM THE ASSURE STUDY by Palak J. Trivedi, Cynthia Levy, Kris V. Kowdley, Stuart C. Gordon, Christopher L. Bowlus, Maria Carlota Londoño Hurtado, Gideon M. Hirschfield, Aliya F. Gulamhusien, Eric J. Lawitz, Alejandra Villamil, Alma Ladron de Guevara Cetina, Marlyn J. Mayo, Ziad H. Younes, Oren Shibolet, Kidist K. Yimam, Daniel S. Pratt, Jeong Heo, Ulrike Morgera, Pietro Andreone, Andreas E. Kremer, Christophe Corpechot, Aparna Goel, Adam Peyton, Hany Elbeshbeshy, Daria B. Crittenden, Carrie Heusner, Sarah Proehl, Shuqiong Zhou, Charles A. McWherter

Get full text

Loss of biochemical response at any time worsens outcomes in UDCA-treated patients with primary biliary cholangitis by Surain B. Roberts, Woo Jin Choi, Lawrence Worobetz, Catherine Vincent, Jennifer A. Flemming, Angela Cheung, Karim Qumosani, Mark Swain, Dusanka Grbic, Hin Hin Ko, Kevork M. Peltekian, Lusine Abrahamyan, Monika Saini, Kattleya Tirona, Bishoi Aziz, Ellina Lytvyak, Pietro Invernizzi, Cyriel Y. Ponsioen, Tony Bruns, Nora Cazzagon, Keith Lindor, George N. Dalekos, Nikolaos K. Gatselis, Xavier Verhelst, Annarosa Floreani, Christophe Corpechot, Marlyn J. Mayo, Cynthia Levy, Maria-Carlota Londoño, Pier M. Battezzati, Albert Pares, Frederik Nevens, Adriaan van der Meer, Kris V. Kowdley, Palak J. Trivedi, Ana Lleo, Douglas Thorburn, Marco Carbone, Nazia Selzner, Aliya F. Gulamhusein, Harry LA. Janssen, Aldo J. Montano-Loza, Andrew L. Mason, Gideon M. Hirschfield, Bettina E. Hansen

Get full text